Ashfield Capital Partners, LLC Merck & Co., Inc. Transaction History

Ashfield Capital Partners, LLC

$1.19 Billion
Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 79,887 shares of MRK stock, worth $7.83 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

79,887

Previous 79,887 -0.0%

Holding current value

$7.83 Million

Previous $7.28 Million 5.53%

% of portfolio

0.58%

Previous 0.57%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $62,777 - $70,369	854 Added 1.08%	79,887 $6.56 Million
Q4 2021 Feb 02, 2022	SELL	$72.28 - $90.54 $43,368 - $54,324	-600 Reduced 0.75%	79,033 $6.06 Million
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $44,154 - $48,559	-616 Reduced 0.77%	79,633 $5.98 Million
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $195,391 - $216,122	-2,779 Reduced 3.35%	80,249 $6.24 Million
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $74,024 - $87,193	-1,075 Reduced 1.28%	83,028 $6.4 Million
Q4 2020 Feb 02, 2021	SELL	$71.77 - $79.65 $51,961 - $57,666	-724 Reduced 0.85%	84,103 $6.88 Million
Q3 2020 Nov 03, 2020	SELL	$73.18 - $82.95 $2,561 - $2,903	-35 Reduced 0.04%	84,827 $7.04 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $278,370 - $316,753	3,953 Added 4.89%	84,862 $6.56 Million
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $18,057 - $25,028	285 Added 0.35%	80,909 $6.23 Million
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $243,135 - $274,350	-3,134 Reduced 3.74%	80,624 $7.33 Million
Q3 2019 Oct 31, 2019	BUY	$76.08 - $82.93 $166,767 - $181,782	2,192 Added 2.69%	83,758 $7.05 Million
Q2 2019 Jul 29, 2019	SELL	$69.84 - $81.59 $19,066 - $22,274	-273 Reduced 0.33%	81,566 $6.84 Million
Q1 2019 Apr 30, 2019	BUY	$69.58 - $79.36 $25,327 - $28,887	364 Added 0.45%	81,839 $6.81 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $11,938 - $13,854	183 Added 0.23%	81,475 $6.23 Million
Q3 2018 Nov 02, 2018	SELL	$57.69 - $67.84 $6,576 - $7,733	-114 Reduced 0.14%	81,292 $5.77 Million
Q1 2018 May 02, 2018	SELL	$50.96 - $59.23 $46,016 - $53,484	-903 Reduced 1.1%	81,406 $4.43 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $176,024 - $210,192	-3,410 Reduced 3.98%	82,309 $4.63 Million
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $352 - $378	6 Added 0.01%	85,719 $5.49 Million
Q2 2017 Aug 14, 2017	BUY	N/A	85,713	85,713 $5.49 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Account

Ashfield Capital Partners, LLC Merck & Co., Inc. Transaction History